Advanced Research Technologies, a developer of diagnostic laser and thermal imaging technologies, has recruited Serge Huot to replace Paul Bisson as president and CEO, effective Oct. 18, the date set for ART’s annual and special meeting of
Advanced Research Technologies, a developer of diagnostic laser and thermal imaging technologies, has recruited Serge Huot to replace Paul Bisson as president and CEO, effective Oct. 18, the date set for ART’s annual and special meeting of shareholders. In the interim, Huot will serve as chief operating officer of ART, working closely with Bisson to ensure a smooth transition. Huot has held different executive positions with various companies, including GE Medical Systems.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.